- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PACE (Prednisone, Abiraterone, Cabazitaxel, and Enzalutamide)
Total 471401 results
-
ORIC PharmaceuticalsTerminated
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedHealthy Subjects | Drug-Drug Interaction (DDI) | Pharmacokinetics of EnzalutamideGermany
-
MedImmune LLCCompletedMetastatic Castration Resistant Prostate CancerUnited States, Switzerland, United Kingdom
-
ESSA PharmaceuticalsRecruitingProstate CancerCanada, United States, Australia
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedProstate Cancer | Pharmacokinetics of EnzalutamideUnited States
-
Centro Nacional de Investigaciones Oncologicas...Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina...UnknownAdvanced Prostate Cancer | Castration Resistant | EnzalutamideSpain
-
Radboud University Medical CenterActive, not recruitingProstatic Neoplasms, Castration-ResistantNetherlands
-
Groupe Hospitalier Pitie-SalpetriereCompletedEpilepsy | Prostate Cancer | Neuropathy | EncephalopathyFrance
-
Hinova Pharmaceuticals Inc.CompletedMetastatic Castration Resistant Prostate CancerChina
-
Macquarie University, AustraliaUnknown
-
Fundación Canaria de Investigación SanitariaHospital Universitario de CanariasUnknown
-
Translational Research Center for Medical Innovation...Kagawa UniversityCompleted
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Completed
-
Andreas JosefssonGöteborg University; Umeå University; Sahlgrenska University Hospital, Sweden; Sundsvall... and other collaboratorsTerminated
-
Rahul AggarwalFortis Therapeutics, Inc.RecruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustUnknownAdenocarcinoma of the ProstateUnited Kingdom
-
Hinova Pharmaceuticals USA, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Prostate Cancer MetastaticGermany, Spain, Denmark, France, United Kingdom, Russian Federation, Poland, Australia, Italy, Netherlands, United States, Finland, Canada, Austria
-
Alessa Therapeutics Inc.National Cancer Institute (NCI)Not yet recruitingProstate AdenocarcinomaUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruitingMetastatic Castrate-resistant Prostate (CRPC) CancerFrance
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)France, Germany, Spain, United States, Argentina, Australia, Belgium, Canada, Chile, Czechia, Finland, Hungary, Israel, Italy, Korea, Republic of, New Zealand, Singapore, Sweden, Taiwan, United Kingdom
-
Grupo Español de Tumores Huérfanos e InfrecuentesAstellas Pharma Inc; Apices Soluciones S.L.Completed
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedProstate Cancer | Castration Resistant Prostate CancerUnited States
-
Astellas Pharma IncPfizerCompletedCastration-resistant Prostate CancerJapan
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedKidney Diseases | Healthy Subjects | Pharmacokinetics of MDV3100Moldova, Republic of
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedHealthy Subjects | Relative Bioavailability | Castration Resistant Prostate Cancer (CRPC) | MDV3100Germany
-
National Cancer Institute (NCI)Terminated
-
European Organisation for Research and Treatment...Bayer; Latin American Cooperative Oncology Group; UNICANCER; Astellas Pharma Europe... and other collaboratorsActive, not recruitingProstate CancerSpain, Belgium, France, Italy, United Kingdom, Denmark, Canada, Ireland, Brazil, Norway, Poland, Switzerland
-
Ricardo Pereira MestreOncology Institute of Southern Switzerland; Institute of Oncology Research; Institute...TerminatedCOVID-19 InfectionSwitzerland
-
Astellas Pharma Europe Ltd.Medivation, Inc.CompletedMetastatic Castration Resistant Prostate CancerCzechia, Netherlands, Denmark, Italy, Austria, Belgium, Bulgaria, France, Germany, Greece, Hungary, Ireland, Portugal, Slovenia, Spain, United Kingdom
-
Astellas Pharma Global Development, Inc.Medivation, Inc.WithdrawnMetastatic Castration-Resistant Prostate Cancer
-
Case Comprehensive Cancer CenterCompletedAdenocarcinoma of the ProstateUnited States
-
PfizerAstellas Pharma IncActive, not recruitingmCRPCChina, Finland, Spain, United States, Hungary, Israel, Belgium, Korea, Republic of, France, Canada, Czechia, Australia, Japan, Brazil, Germany, Argentina, New Zealand, United Kingdom, Norway, South Africa, Poland, Portugal, Chile, Italy, Pe... and more
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteRecruitingProstate Cancer | Prostate Adenocarcinoma | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)United States
-
Syntrix Biosystems, Inc.National Cancer Institute (NCI)RecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Zenith EpigeneticsEnrolling by invitation
-
Weill Medical College of Cornell UniversitySagimet Biosciences Inc.RecruitingProstatic Neoplasms, Castration-ResistantUnited States
-
OHSU Knight Cancer InstituteAstellas Pharma US, Inc.; Oregon Health and Science UniversityActive, not recruitingCastration-Resistant Prostate Carcinoma | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Soft Tissues | Recurrent Prostate Carcinoma | Metastatic Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma AJCC v7 | Stage IV Prostate Adenocarcinoma AJCC v7United States
-
BayerTerminatedProstatic Cancer, Castration-ResistantUnited States
-
Astellas Pharma Global Development, Inc.PfizerCompletedAdvanced Hepatocellular CarcinomaCanada, United States, Hong Kong, Italy, Korea, Republic of, Puerto Rico, Spain, Taiwan, United Kingdom
-
AstraZenecaParexelCompleted
-
Zenith EpigeneticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
Zhongnan HospitalRecruitingProstate Cancer | Castrate Resistant Prostate CancerChina
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma Inc; Medivation, Inc.Active, not recruitingBreast Cancer | Triple Negative Breast Cancer | Early StageUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedBreast CancerUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerUnited States
-
RTOG Foundation, Inc.Pfizer; Astellas Pharma IncActive, not recruitingProstate CancerUnited States, Canada
-
Kangpu Biopharmaceuticals, Ltd.CompletedCastration-Resistant Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate CancerUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterMayo Clinic; Washington University School of Medicine; Astellas Pharma US, Inc.; University of Southern California and other collaboratorsCompletedHepatocellular CarcinomaUnited States